131 related articles for article (PubMed ID: 27865605)
1. Population pharmacokinetic model of lithium and drug compliance assessment.
Pérez-Castelló I; Mangas-Sanjuan V; González-García I; Gonzalez-Alvarez I; Bermejo M; Marco-Garbayo JL; Trocóniz IF
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1868-1876. PubMed ID: 27865605
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring of lithium in patients with bipolar affective disorder: experiences from a tertiary care hospital in India.
Sharma S; Joshi S; Chadda RK
Am J Ther; 2009; 16(5):393-7. PubMed ID: 19262359
[TBL] [Abstract][Full Text] [Related]
3. Estimation of lithium clearance in patients with bipolar disorder.
Alqahtani S; Aljuma'ah N; Aydan NB; Alsultan A; Alsarhani E; Asiri Y
Int Clin Psychopharmacol; 2020 May; 35(3):157-162. PubMed ID: 31851034
[TBL] [Abstract][Full Text] [Related]
4. Perioperative Lithium Use in Bariatric Surgery: A Case Series and Literature Review.
Bingham KS; Thoma J; Hawa R; Sockalingam S
Psychosomatics; 2016; 57(6):638-644. PubMed ID: 27726858
[No Abstract] [Full Text] [Related]
5. Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.
Landersdorfer CB; Findling RL; Frazier JA; Kafantaris V; Kirkpatrick CM
Clin Pharmacokinet; 2017 Jan; 56(1):77-90. PubMed ID: 27393139
[TBL] [Abstract][Full Text] [Related]
6. Lithium in bipolar and other affective disorders: prescribing practice in the UK.
Paton C; Barnes TR; Shingleton-Smith A; McAllister-Williams RH; Kirkbride J; Jones PB; McIntyre S;
J Psychopharmacol; 2010 Dec; 24(12):1739-46. PubMed ID: 20488832
[TBL] [Abstract][Full Text] [Related]
7. A Selective Association between Central and Peripheral Lithium Levels in Remitters in Bipolar Depression: A 3T-(7) Li Magnetic Resonance Spectroscopy Study.
Machado-Vieira R; Otaduy MC; Zanetti MV; De Sousa RT; Dias VV; Leite CC; Forlenza OV; Busatto GF; Soares JC; Gattaz WF
Acta Psychiatr Scand; 2016 Mar; 133(3):214-20. PubMed ID: 26513535
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens.
Methaneethorn J
Clin Ther; 2017 Jun; 39(6):1171-1181. PubMed ID: 28483293
[TBL] [Abstract][Full Text] [Related]
9. First-dose pharmacokinetics of lithium carbonate in children and adolescents.
Findling RL; Landersdorfer CB; Kafantaris V; Pavuluri M; McNamara NK; McClellan J; Frazier JA; Sikich L; Kowatch R; Lingler J; Faber J; Taylor-Zapata P; Jusko WJ
J Clin Psychopharmacol; 2010 Aug; 30(4):404-10. PubMed ID: 20531219
[TBL] [Abstract][Full Text] [Related]
10. Rapid onset of neurological symptoms and lithium toxicity on starting meloxicam.
Chen L; Pym H
Aust N Z J Psychiatry; 2010 Jan; 44(1):95. PubMed ID: 20073572
[No Abstract] [Full Text] [Related]
11. Long-term lithium treatment and survival from external causes including suicide.
Bocchetta A; Fadda D; Satta G; Del Zompo M; Gessa GL; Cocco P
J Clin Psychopharmacol; 2007 Oct; 27(5):544-6. PubMed ID: 17873708
[No Abstract] [Full Text] [Related]
12. Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot study.
Zanetti MV; Otaduy MC; de Sousa RT; Gattaz WF; Busatto GF; Leite CC; Machado-Vieira R
Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522399
[TBL] [Abstract][Full Text] [Related]
13. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
14. Compliance with the safety guidelines for long-term lithium treatment in Sweden.
Golic M; Aiff H; Attman PO; Ramsauer B; Schön S; Svedlund J
J Psychopharmacol; 2018 Oct; 32(10):1104-1109. PubMed ID: 29896998
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
[No Abstract] [Full Text] [Related]
16. Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach.
ElDesoky ES; Kumar V; Alorainy MS; Hamdi MM; Derendorf H
Int J Clin Pharmacol Ther; 2008 Dec; 46(12):617-26. PubMed ID: 19049695
[TBL] [Abstract][Full Text] [Related]
17. Appropriateness of therapeutic drug monitoring for lithium.
Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
[TBL] [Abstract][Full Text] [Related]
18. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
Haymond J; Ensom MH
Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
[TBL] [Abstract][Full Text] [Related]
20. Monitoring lithium therapy: the impact of a quality improvement programme in the UK.
Paton C; Adroer R; Barnes TR
Bipolar Disord; 2013 Dec; 15(8):865-75. PubMed ID: 24119180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
